Jensen, S. B. K. et al. Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial. JAMA Netw. Open 7, e2416775 (2024).
Article PubMed PubMed Central Google Scholar
Mollan, S. P. Semaglutide and nonarteritic anterior ischemic optic neuropathy. JAMA Ophthalmol. 142, 740–741 (2024).
Kelly, J., Karlsen, M. & Steinke, G. Type 2 diabetes remission and lifestyle medicine: a position statement from the American College of Lifestyle Medicine. Am. J. Lifestyle Med. 14, 406–419 (2020).
Article PubMed PubMed Central Google Scholar
Manoogian, E. N. C. et al. Time-restricted eating in adults with metabolic syndrome: a randomized controlled trial. Ann. Intern. Med. 177, 1462–1470 (2024).
Che, T. et al. Time-restricted feeding improves blood glucose and insulin sensitivity in overweight patients with type 2 diabetes: a randomised controlled trial. Nutr. Metab. 18, 88 (2021).
Ezpeleta, M. et al. Time-restricted eating: eatching the clock to treat obesity. Cell Metab. 36, 301–314 (2024).
Article CAS PubMed PubMed Central Google Scholar
Guo, L. et al. A 5:2 intermittent fasting meal replacement diet and glycemic control for adults with diabetes: the EARLY randomized clinical trial. JAMA Netw. Open 7, e2416786 (2024).
Article PubMed PubMed Central Google Scholar
van den Burg, E. L. et al. Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial. Diabetologia 67, 1245–1259 (2024).
Article PubMed PubMed Central Google Scholar
Sulaj, A. et al. Six-month periodic fasting in patients with type 2 diabetes and diabetic nephropathy: a proof-of-concept study. J. Clin. Endocrinol. Metab. 107, 2167–2181 (2022).
Article PubMed PubMed Central Google Scholar
Hofer, S. J. et al. Spermidine is essential for fasting-mediated autophagy and longevity. Nat. Cell Biol. 26, 1571–1584 (2024).
留言 (0)